File size: 20,129 Bytes
4b458bc | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 | {
"totalErrors": 1122,
"errorRate": 0.0832,
"topConfusions": [
{
"expected": "COMPLIANCE",
"predicted": "GOVERNING_LAW",
"count": 55
},
{
"expected": "OTHER",
"predicted": "PAYMENT",
"count": 29
},
{
"expected": "OTHER",
"predicted": "WAIVER",
"count": 28
},
{
"expected": "ASSIGNMENT",
"predicted": "OTHER",
"count": 26
},
{
"expected": "PAYMENT",
"predicted": "OTHER",
"count": 22
},
{
"expected": "DISPUTE_RESOLUTION",
"predicted": "GOVERNING_LAW",
"count": 22
},
{
"expected": "OTHER",
"predicted": "REPRESENTATIONS",
"count": 22
},
{
"expected": "OTHER",
"predicted": "ASSIGNMENT",
"count": 19
},
{
"expected": "REPRESENTATIONS",
"predicted": "OTHER",
"count": 18
},
{
"expected": "WAIVER",
"predicted": "OTHER",
"count": 17
},
{
"expected": "LICENSE_GRANT",
"predicted": "EXCLUSIVITY",
"count": 16
},
{
"expected": "PAYMENT",
"predicted": "EXPENSES",
"count": 16
},
{
"expected": "TERM_AND_DURATION",
"predicted": "OTHER",
"count": 16
},
{
"expected": "OTHER",
"predicted": "COMPLIANCE",
"count": 16
},
{
"expected": "REPRESENTATIONS",
"predicted": "WARRANTY",
"count": 15
}
],
"errorRateByDataset": {
"CUAD": 0.1249,
"LEDGAR": 0.0773
},
"samples": [
{
"documentId": "CUAD:MetLife, Inc. - Remarketing Agreement",
"dataset": "CUAD",
"expected": "TERM_AND_DURATION",
"predicted": "TERMINATION",
"text": "obligations of the Remarketing Agents may be terminated by them by notice given to the Company prior to 12:00 noon, New York City time on the Remarketing Settlement Date if, prior to that time, any of the applicable conditions precedent to the obligations of the Remarketing Agents described in Section 5 hereof shall have failed to occur."
},
{
"documentId": "CUAD:MetLife, Inc. - Remarketing Agreement",
"dataset": "CUAD",
"expected": "INSURANCE",
"predicted": "COMPLIANCE",
"text": "as an insurance company in its respective jurisdiction of incorporation and is duly licensed or authorized as an insurer in each other jurisdiction where it is required to be so licensed or authorized to conduct its business, in each case with such exceptions as would not have, individually or in the aggregate, a Material Adverse Effect; except as otherwise described in the Disclosure Package, eac"
},
{
"documentId": "CUAD:MetLife, Inc. - Remarketing Agreement",
"dataset": "CUAD",
"expected": "INSURANCE",
"predicted": "COMPLIANCE",
"text": "Each Insurance Subsidiary is in compliance with and conducts its businesses in conformity with all applicable insurance laws and regulations of its respective jurisdiction of incorporation and the insurance laws and regulations of other jurisdictions which are applicable to it, in each case with such exceptions as would not have, individually or in the aggregate, a Material Adverse Effect."
},
{
"documentId": "CUAD:SIBANNAC,INC_12_04_2017-EX-2.1-Strategic Alliance Agreement",
"dataset": "CUAD",
"expected": "RENEWAL",
"predicted": "TERM_AND_DURATION",
"text": "The term of this Agreement is twelve (12) months from the date hereof, and will be automatically renewed for one (1) additional twelve month period unless either party shall notify the other in writing of its intention not to renew. Such notice must be given ninety (90) days prior to expiration of the original term."
},
{
"documentId": "CUAD:OPERALTD_04_30_2020-EX-4.14-SERVICE AGREEMENT",
"dataset": "CUAD",
"expected": "RENEWAL",
"predicted": "CONFIDENTIALITY",
"text": "4.7 Data protection. Each Party agrees to comply with all applicable data protection and privacy laws arising from its obligations, if any, under the Agreement and to reasonably co-operate with the other Party in order to allow the other Party to comply with any laws as deemed necessary from time to time. Each Party shall treat all data, information relating to Services, including but not limit to"
},
{
"documentId": "CUAD:OPERALTD_04_30_2020-EX-4.14-SERVICE AGREEMENT",
"dataset": "CUAD",
"expected": "RENEWAL",
"predicted": "LICENSE_GRANT",
"text": "knowingly use the Services in violation of this Agreement."
},
{
"documentId": "CUAD:OPERALTD_04_30_2020-EX-4.14-SERVICE AGREEMENT",
"dataset": "CUAD",
"expected": "RENEWAL",
"predicted": "CONFIDENTIALITY",
"text": "knowingly use the Services in violation of this Agreement. 3\n\n\n\n\n\n4.7 Data protection. Each Party agrees to comply with all applicable data protection and privacy laws arising from its obligations, if any, under the Agreement and to reasonably co-operate with the other Party in order to allow the other Party to comply with any laws as deemed necessary from time to time. Each Party shall treat all "
},
{
"documentId": "CUAD:HealthcareIntegratedTechnologiesInc_20190812_8-K_EX-10.1_11776966_EX-10.1_Reseller Agreement",
"dataset": "CUAD",
"expected": "RENEWAL",
"predicted": "TERMINATION",
"text": "Following the Initial Term, either Party may terminate this Agreement without cause upon written notice to the other Party of at least 3 months."
},
{
"documentId": "CUAD:BNCMORTGAGEINC_05_17_1999-EX-10.4-LICENSING AND WEB SITE HOSTING AGREEMENT",
"dataset": "CUAD",
"expected": "SCOPE_OF_WORK",
"predicted": "PAYMENT",
"text": "Client will pay TrueLink's fees for requested Hosting Services and Support Services pursuant to the schedule of charges set forth on Exhibits \"A\" and \"B\" attached hereto, (but not less than $____ per month for the Hosting Services and $____ per month for Support Services)."
},
{
"documentId": "CUAD:CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement",
"dataset": "CUAD",
"expected": "NON_COMPETE",
"predicted": "CHANGE_OF_CONTROL",
"text": "CytoDyn shall have the right to terminate this Agreement in its entirety upon written notice to Vyera on the occurrence of any of the following:"
},
{
"documentId": "CUAD:CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement",
"dataset": "CUAD",
"expected": "TERMINATION",
"predicted": "CHANGE_OF_CONTROL",
"text": "Vyera shall have the right to terminate this Agreement in its entirety:"
},
{
"documentId": "CUAD:CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement",
"dataset": "CUAD",
"expected": "LICENSE_GRANT",
"predicted": "OTHER",
"text": "Vyera shall have the exclusive right to implement, and subject to Section 5.5, final decision-making authority with respect to, Commercialization of all Licensed Products in the Field and the Territory."
},
{
"documentId": "CUAD:CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement",
"dataset": "CUAD",
"expected": "LICENSE_GRANT",
"predicted": "NON_COMPETE",
"text": "Vyera shall not Commercialize nor shall it authorize the Commercialization of any Licensed Product outside of the Field or outside of the Territory."
},
{
"documentId": "CUAD:GALACTICOMMTECHNOLOGIESINC_11_07_1997-EX-10.46-WEB HOSTING AGREEMENT",
"dataset": "CUAD",
"expected": "LICENSE_GRANT",
"predicted": "SURVIVAL",
"text": "In the event Galacticomm, Inc. chooses to terminate this agreement, Horst Entertainment Inc. will have the right to purchase a license copy of the software in the amount of $15,000.00."
},
{
"documentId": "CUAD:GridironBionutrientsInc_20171206_8-K_EX-10.2_10972556_EX-10.2_Endorsement Agreement",
"dataset": "CUAD",
"expected": "PAYMENT",
"predicted": "OTHER",
"text": "The NFLA-NC will donate 15% of the above described proceeds to the NFLA."
},
{
"documentId": "CUAD:FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement",
"dataset": "CUAD",
"expected": "NON_COMPETE",
"predicted": "NON_SOLICITATION",
"text": "The Distributor shall not:"
},
{
"documentId": "CUAD:FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement",
"dataset": "CUAD",
"expected": "AUDIT_RIGHTS",
"predicted": "LICENSE_GRANT",
"text": "The Distributor undertakes and agrees with the Supplier that at all times during the Term it will:"
},
{
"documentId": "CUAD:FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement",
"dataset": "CUAD",
"expected": "DISPUTE_RESOLUTION",
"predicted": "PUBLICITY",
"text": "The Distributor shall not do, or omit to do, anything in its use of the Trade Marks that could adversely affect their validity or the goodwill of the Supplier."
},
{
"documentId": "CUAD:FreezeTagInc_20180411_8-K_EX-10.1_11139603_EX-10.1_Sponsorship Agreement",
"dataset": "CUAD",
"expected": "LICENSE_GRANT",
"predicted": "EXCLUSIVITY",
"text": "The Association Marks shall not be placed adjacent to the mark of another organization concerned with diabetes, or those of a company that manufactures products or provides services related to diabetes, without the Association's specific prior written consent, which may be withheld for any reason."
},
{
"documentId": "CUAD:FreezeTagInc_20180411_8-K_EX-10.1_11139603_EX-10.1_Sponsorship Agreement",
"dataset": "CUAD",
"expected": "LICENSE_GRANT",
"predicted": "EXCLUSIVITY",
"text": "Any display of Association Mark must be accompanied by one of the following relationship statements: a. \"Freeze Tag is a national sponsor of Get Fit Don't Sit DayTM, a wellness engagement day of American Diabetes Association\u00ae\" b. \"Freeze Tag is a national sponsor of American Diabetes Association\u00ae\""
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "OTHER",
"predicted": "NON_COMPETE",
"text": "The party specified as the Franchisee on SCHEDULE 1 attached hereto"
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "NON_COMPETE",
"predicted": "NON_SOLICITATION",
"text": "The Franchisee will not attempt, directly or indirectly, to entice or induce any employee of BKC or of an Affiliate of BKC or of another franchisee of BKC to leave such employment, nor to employ such employee within six (6) months after his or her termination of employment with such employer, except with the prior written consent of such employer."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "PUBLICITY",
"predicted": "DISPUTE_RESOLUTION",
"text": "The Franchisee will not directly or indirectly, at any time during the term of this Agreement or thereafter, do or cause to be done any act or thing disputing, attacking or in any way impairing the validity of and BKC's right, title or interest in the Burger King Marks and the Burger King System."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "EXCLUSIVITY",
"predicted": "WARRANTY",
"text": "Silence on the part of BKC shall constitute rejection."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "CHANGE_OF_CONTROL",
"predicted": "COMPLIANCE",
"text": "BKC may impose reasonable conditions on its consent to the transfers contemplated in Subparagraphs 15.1 and 15.2 above. BKC is under no obligation to consent to the encumbrances contemplated in Subparagraphs 15.1 and 15.2 above, and may deny its consent to such encumbrances in its sole discretion."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "ASSIGNMENT",
"predicted": "CHANGE_OF_CONTROL",
"text": "grant or deliver any additional equity interests in the Franchisee, or (c) sell, assign, transfer, convey, or give away substantially all of the assets of the Franchised Restaurant."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "SCOPE_OF_WORK",
"predicted": "AUDIT_RIGHTS",
"text": "A representative of BKC who shall make not less than two (2) one day visits to Poland per annum to provide the Franchisee with any requested reasonable operations or marketing guidance and advice."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "INTELLECTUAL_PROPERTY",
"predicted": "OTHER",
"text": "and other franchisees. The Franchisee agrees to execute any additional documents which BKC may deem necessary to effect or perfect the provisions of this Paragraph 5.12."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "INTELLECTUAL_PROPERTY",
"predicted": "OTHER",
"text": "The Franchisee agrees to execute any additional documents which BKC may deem necessary to effect or perfect the provisions of this Paragraph 5.12."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "INTELLECTUAL_PROPERTY",
"predicted": "EXCLUSIVITY",
"text": "The Franchisee acknowledges and agrees that all such potential improvements and new features shall become the exclusive property of BKC without payment of any consideration to the Franchisee, and BKC is free to evaluate such potential improvements or new features in its own restaurants and introduce any such improvements or new features into the Burger King System for the benefi"
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "SURVIVAL",
"predicted": "EXCLUSIVITY",
"text": "The Franchisee grants to BKC or its designee upon termination or expiration of this Agreement, the option to purchase all usable paper goods, containers and printed menus bearing any of the Burger King Marks or trade names at the price paid by the Franchisee and to purchase the Franchisee's restaurant equipment, furniture, fixtures and signs at fair market value."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "SURVIVAL",
"predicted": "EXCLUSIVITY",
"text": "Upon termination or expiration of this Agreement, if the parties do not enter into a successor Franchise Agreement whereby the Franchisee shall continue to be a franchisee and operate the Franchised Restaurant at the Location, BKC or its designee shall have the option subject to obtaining any necessary governmental consent:"
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "SURVIVAL",
"predicted": "ASSIGNMENT",
"text": "(b) If the Location is leased by the Franchisee, any of the Principals or an affiliate of the Franchisee, subject to obtaining any necessary landlord's consent, to obtain an assignment of the leasehold interest at a price equal to the fair market value of the leasehold interest."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "SURVIVAL",
"predicted": "EXCLUSIVITY",
"text": "Upon termination or expiration of this Agreement, if the parties do not enter into a successor Franchise Agreement whereby the Franchisee shall continue to be a franchisee and operate the Franchised Restaurant at the Location, BKC or its designee shall have the option subject to obtaining any necessary governmental consent:\n\n (a) To purchase the Location a"
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "AUDIT_RIGHTS",
"predicted": "REPRESENTATIONS",
"text": "Within ninety (90) days after the close of each fiscal year and at any time on request, the Franchisee shall submit a full disclosure of all shareholders in the Franchisee, and of all persons with an interest in the Franchised Restaurant."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "AUDIT_RIGHTS",
"predicted": "REPRESENTATIONS",
"text": "ln addition, the Franchisee shall furnish an annual financial statement for the Franchisee and not merely the Franchised Restaurant, which statement shall be certified by a Certified Public Accountant or equivalent."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "AUDIT_RIGHTS",
"predicted": "REPRESENTATIONS",
"text": "The Franchisee shall also submit to BKC quarterly balance sheets for the Franchisee itself and not merely of the Franchised Restaurant, the first of which shall be for the period ending forty-five (45) days after the expiration of the first calendar quarter after the Franchised Restaurant opens."
},
{
"documentId": "CUAD:INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT",
"dataset": "CUAD",
"expected": "AUDIT_RIGHTS",
"predicted": "REPRESENTATIONS",
"text": "All profit and loss statements and balance sheets shall be submitted to BKC within fifty-five (45) days after the end of the period covered by the report in a form acceptable to BKC."
},
{
"documentId": "CUAD:BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT",
"dataset": "CUAD",
"expected": "EXCLUSIVITY",
"predicted": "SURVIVAL",
"text": "Biocept will have sole responsibility for performing the Technical Component of all Tests sold by the parties, until and unless Life Technologies obtains the right from Biocept to independently develop its own Tests in accordance with all applicable FDA regulatory requirements, as provided for in Section 7.1."
},
{
"documentId": "CUAD:BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT",
"dataset": "CUAD",
"expected": "NON_COMPETE",
"predicted": "LICENSE_GRANT",
"text": "Life Technologies will be authorized to perform the Professional Component of all Tests sold by the parties, although Biocept may engage other groups in promotion, marketing and performance arrangements for the Tests, at the discretion of Biocept."
}
]
} |